Tuberc Respir Dis.  2013 Nov;75(5):210-213.

An Unusual Case of Superior Vena Cava Syndrome Caused by the Intravascular Invasion of an Invasive Thymoma

Affiliations
  • 1Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea. kimdh@dankook.ac.kr
  • 2Department of Thoracic and Cardiovascular Surgery, Dankook University College of Medicine, Cheonan, Korea.
  • 3Department of Radiology, Dankook University College of Medicine, Cheonan, Korea.
  • 4Department of Pathology, Dankook University College of Medicine, Cheonan, Korea.
  • 5Department of Nuclear Medicine, Dankook University College of Medicine, Cheonan, Korea.

Abstract

Superior vena cava syndrome (SVCS) is usually caused by extrinsic compression or invasion of the superior vena cava (SVC) by malignant tumors involving mediastinal structures. Although thymomas are well-known causes of SVCS, cases of SVCS caused by malignant thymomas protruding into adjacent vessels draining the SVC with thrombosis have been very rarely reported worldwide. We experienced a 39-year-old female patient with SVCS that developed after the direct invasion of the left brachiocephalic vein (LBCV) and SVC by an anterior mediastinal mass with a high maximum standardized uptake value on the chest computed tomography (CT) and positron emission tomography-CT. Based on these results, she underwent en bloc resection of the tumor, including removal of the involved vessels, and was eventually diagnosed as having a type B2 thymoma permeating into the LBCV and SVC. We present this case as a very rare form of SVCS caused by an invasive thymoma.

Keyword

Thymoma; Superior Vena Cava Syndrome; Positron-Emission Tomography

MeSH Terms

Adult
Brachiocephalic Veins
Electrons
Female
Humans
Positron-Emission Tomography
Superior Vena Cava Syndrome*
Thorax
Thrombosis
Thymoma*
Vena Cava, Superior*

Figure

  • Figure 1 A massive thrombosis in the left brachiocephalic vein and the superior vena cava extending into the right atrium is observed in the chest computed tomography.

  • Figure 2 The positron emission tomography-computed tomography shows hypermetabolic activity with a maximum standardized uptake value of 6.0 for the anterior mediastinal mass and thrombosis.

  • Figure 3 (A) The superior vena cava thrombus. Macroscopically, the thrombus is soft and dark red, similar to fish flesh. (B) Microscopically, the tumor cells grow in a solid pattern within the large vessels (H&E stain, ×40). (C) The tumor shows a type B2 thymoma with a predominance of large and polygonal epithelial cells with round or elongated nuclei. Considerable numbers of non-neoplastic small lymphocytes mixed with the tumor can be observed (H&E stain, ×400).


Reference

1. Herscovici R, Szyper-Kravitz M, Altman A, Eshet Y, Nevo M, Agmon-Levin N, et al. Superior vena cava syndrome: changing etiology in the third millennium. Lupus. 2012; 21:93–96.
2. Wan JF, Bezjak A. Superior vena cava syndrome. Emerg Med Clin North Am. 2009; 27:243–255.
3. Yu M, Shi A, Jin B, Jiang X, Liang H, Ouyang C. Superior vena cava occlusion caused by Behcet disease. J Vasc Surg. 2012; 55:1488–1491.
4. Airan B, Sharma R, Iyer KS, Kalia PK, Singh MK, Shrivastava S, et al. Malignant thymoma presenting as intracardiac tumor and superior vena caval obstruction. Ann Thorac Surg. 1990; 50:989–991.
5. Terada Y, Ono N, Noguchi T, Kamakari K, Kitano M. A case of thymoma protruding into the superior vena cava through the thymic vein. Ann Thorac Surg. 2004; 77:1088–1090.
6. Yamazaki K, Takeo S, Takeshita M, Sugimachi K. Thymic carcinoma presenting as an intraluminal growth into the great vessels and the cardiac cavity. Ann Thorac Cardiovasc Surg. 2002; 8:163–166.
7. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981; 48:2485–2492.
8. Engels EA, Pfeiffer RM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer. 2003; 105:546–551.
9. Schmidt-Wolf IG, Rockstroh JK, Schuller H, Hirner A, Grohe C, Muller-Hermelink HK, et al. Malignant thymoma: current status of classification and multimodality treatment. Ann Hematol. 2003; 82:69–76.
10. Lewis JE, Wick MR, Scheithauer BW, Bernatz PE, Taylor WF. Thymoma: a clinicopathologic review. Cancer. 1987; 60:2727–2743.
11. Tseng YL, Wang ST, Wu MH, Lin MY, Lai WW, Cheng FF. Thymic carcinoma: involvement of great vessels indicates poor prognosis. Ann Thorac Surg. 2003; 76:1041–1045.
12. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Pathology and genetics of tmours of the lung, pleura, thymus and heart. Lyon: IARC Press;2004.
13. Eguchi T, Yoshida K, Hamanaka K, Shiina T, Koizumi T, Kawakami S, et al. Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours. Eur J Cardiothorac Surg. 2012; 41:1059–1062.
14. Terzi A, Bertolaccini L, Rizzardi G, Luzzi L, Bianchi A, Campione A, et al. Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms. Lung Cancer. 2011; 74:239–243.
15. Davenport E, Malthaner RA. The role of surgery in the management of thymoma: a systematic review. Ann Thorac Surg. 2008; 86:673–684.
Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr